Literature DB >> 12703290

Improved host range selection for recombinant modified vaccinia virus Ankara.

Caroline Staib1, Marianne Löwel, Volker Erfle, Gerd Sutter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12703290     DOI： 10.2144/03344bm02

Source DB:  PubMed          Journal:  Biotechniques        ISSN： 0736-6205            Impact factor:   1.993


× No keyword cloud information.
  14 in total

1.  N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.

Authors:  Meike S Gratz; Yasemin Suezer; Melanie Kremer; Asisa Volz; Monir Majzoub; Kay-Martin Hanschmann; Ulrich Kalinke; Astrid Schwantes; Gerd Sutter
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

Authors:  Karin M Sperling; Astrid Schwantes; Caroline Staib; Barbara S Schnierle; Gerd Sutter
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

3.  Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk.

Authors:  Genevieve G A Fouda; Joshua D Amos; Andrew B Wilks; Justin Pollara; Caroline A Ray; Anjali Chand; Erika L Kunz; Brooke E Liebl; Kaylan Whitaker; Angela Carville; Shannon Smith; Lisa Colvin; David J Pickup; Herman F Staats; Glenn Overman; Krissey Eutsey-Lloyd; Robert Parks; Haiyan Chen; Celia Labranche; Susan Barnett; Georgia D Tomaras; Guido Ferrari; David C Montefiori; Hua-Xin Liao; Norman L Letvin; Barton F Haynes; Sallie R Permar
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

4.  Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara.

Authors:  Philip J R Price; Bruno Luckow; Lino E Torres-Domínguez; Christine Brandmüller; Julia Zorn; Carsten J Kirschning; Gerd Sutter; Michael H Lehmann
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

5.  Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.

Authors:  Michael H Lehmann; Wolfgang Kastenmuller; Judith D Kandemir; Florian Brandt; Yasemin Suezer; Gerd Sutter
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

6.  Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine model.

Authors:  Miriam Nörder; Pablo D Becker; Ingo Drexler; Claudia Link; Volker Erfle; Carlos A Guzmán
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

7.  Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites.

Authors:  Benjamin Kraus; Klaus Boller; Andreas Reuter; Barbara S Schnierle
Journal:  Retrovirology       Date:  2011-03-23       Impact factor: 4.602

8.  Vaccination directed against the human endogenous retrovirus-K envelope protein inhibits tumor growth in a murine model system.

Authors:  Benjamin Kraus; Katrin Fischer; Sarah M Büchner; Winfried S Wels; Roswitha Löwer; Katja Sliva; Barbara S Schnierle
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

9.  Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

Authors:  Matthew G Cottingham; Rikke F Andersen; Alexandra J Spencer; Saroj Saurya; Julie Furze; Adrian V S Hill; Sarah C Gilbert
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

10.  Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8⁺ T Cell Epitopes.

Authors:  Pablo D Becker; Miriam Nörder; Sebastian Weissmann; Ronny Ljapoci; Volker Erfle; Ingo Drexler; Carlos A Guzmán
Journal:  Vaccines (Basel)       Date:  2014-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.